Artificial intelligence is transforming the landscape of biomaterials research — and the breakthroughs happening right now will shape the next generation of medicine. Join Cell Press on July 16, 2026 for a live 90-minute webinar bringing together three pioneering researchers at the intersection of AI, biomedical engineering, and translational science. Joseph C. Wu (Professor & Director, Stanford Cardiovascular Institute; Co-founder, Greenstone Biosciences), Cesar de la Fuente (Presidential Associate Professor, University of Pennsylvania), and Kam W. Leong (Samuel Y. Sheng Professor of Biomedical Engineering, Columbia University) will share cutting-edge insights into how machine learning, generative AI, and data-driven discovery are accelerating the design, screening, and development of next-generation biomaterials for real-world clinical applications. From AI-guided drug delivery systems and smart scaffolds to computational tools for predicting material-tissue interactions, this session will tackle the most pressing questions in the field, and where the science is headed next.
Moderated by the editors of the Cell Press journals Cell Biomaterials, Cell Reports Medicine, and Matter, this is a rare opportunity to engage directly with leading voices shaping how AI-powered biomaterials research reaches patients. Whether your work spans tissue engineering, regenerative medicine, nanomedicine, material science, or translational research, this webinar offers the interdisciplinary perspectives needed to stay at the forefront of a rapidly evolving field. Register now to join the live discussion, submit your questions to the speakers, and receive on-demand access to the recording.
